Company Visit: Exploring Bioinformatics and Career Opportunities at BostonGene

​IMPORTANT: To secure your spot, you must fill in this application form first.

We are pleased to announce that TUMO Labs and BostonGene are jointly organizing a special event, during which participants will have the opportunity to visit BostonGene’s Yerevan office, learn more about the company’s work, and attend a lecture delivered by a senior bioinformatics expert from BostonGene.

​BostonGene is redefining cancer patient care and drug development through the integration of omnimodal data and artificial intelligence. Built and validated through an extensive real-world clinical testing network, BostonGene’s foundation model for tumor and immune biology integrates genomic, transcriptomic, and immune data with clinical outcomes to generate biologically grounded, actionable insights. These insights enable biopharma partners to design and de-risk clinical trials, identify novel therapeutic targets, and optimize treatment response prediction across all stages of drug development, while simultaneously improving patient care through clinically integrated innovation.

​The event agenda includes:

• ​Introduction to BostonGene

• ​Introduction to bioinformatics and its applications

• ​Career development opportunities and industry insights

• ​Interactive Q&A session with students

• ​Office tour of BostonGene’s Yerevan office

​Speaker

​Konstantin Chernyshov
Head of NGS Bioinformatics | Precision Oncology Expert

​Konstantin Chernyshov is a bioinformatics leader with 6 years of experience in next-generation sequencing (NGS), cancer genomics, and precision oncology. He specializes in the analysis of tumor genomic and transcriptomic data, molecular classification of cancers, and the development of advanced biomedical solutions for pharmaceutical companies.